Localization of COX-1 and COX-2 in the intracranial dura mater of the rat

Neuroscience Letters

Volumn 452, Issue 1, 2009, Pages 33-36

  Zhang, Xi Chun ^a   Kainz, Vanessa ^a   Jakubowski, Moshe ^a   Burstein, Rami ^a   Strassman, Andrew ^a   Levy, Dan ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cyclooxygenase; Dura; Headache; Inflammation; Migraine; NSAID; Trigeminal

Indexed keywords

CELL MARKER; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; NITRIC OXIDE SYNTHASE; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL TYPE; CONTROLLED STUDY; DURA MATER; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; MALE; MENINX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BLOOD VESSELS; CALCITONIN GENE-RELATED PEPTIDE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DURA MATER; ECTODYSPLASINS; MACROPHAGES; MALE; MEMBRANE PROTEINS; NITRIC OXIDE SYNTHASE TYPE III; PIA MATER; RATS; RATS, SPRAGUE-DAWLEY; VIMENTIN;

EID: 59349093730     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.01.032     Document Type: Article

References (27)

1. Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain 89 (2001) 107-110
2. Chopra B., Giblett S., Little J.G., Donaldson L.F., Tate S., Evans R.J., and Grubb B.D. Cyclooxygenase-1 is a marker for a subpopulation of putative nociceptive neurons in rat dorsal root ganglia. Eur. J. Neurosci. 12 (2000) 911-920
3. Dou W., Jiao Y., Goorha S., Raghow R., and Ballou L.R. Nociception and the differential expression of cyclooxygenase-1 (COX-1), the COX-1 variant retaining intron-1 (COX-1 v), and COX-2 in mouse dorsal root ganglia (DRG). Prostaglandins Other Lipid Mediators 74 (2004) 29-43
4. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., and Lipsky P.E. Cyclooxygenase in biology and disease. Faseb J. 12 (1998) 1063-1073
5. Ghilardi J.R., Svensson C.I., Rogers S.D., Yaksh T.L., and Mantyh P.W. Constitutive spinal cyclooxygenase-2 participates in the initiation of tissue injury-induced hyperalgesia. J. Neurosci. 24 (2004) 2727-2732
6. Hill J.M., Lukiw W.J., Gebhardt B.M., Higaki S., Loutsch J.M., Myles M.E., Thompson H.W., Kwon B.S., Bazan N.G., and Kaufman H.E. Gene expression analyzed by microarrays in HSV-1 latent mouse trigeminal ganglion following heat stress. Virus Genes 23 (2001) 273-280
7. Inoue A., Iwasa M., Nishikura Y., Ogawa S., Nakasuka A., and Nakata Y. The long-term exposure of rat cultured dorsal root ganglion cells to bradykinin induced the release of prostaglandin E2 by the activation of cyclooxygenase-2. Neurosci. Lett. 401 (2006) 242-247
8. Jakubowski M., Levy D., Goor-Aryeh I., Collins B., Bajwa Z., and Burstein R. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache 45 (2005) 850-861
9. Khalil M.H., Silverman A.J., and Silver R. Mast cells in the rat brain synthesize gonadotropin-releasing hormone. J. Neurobiol. 56 (2003) 113-124
10. Kobayashi S., Baba H., Uchida K., Kokubo Y., Kubota C., Yamada S., Suzuki Y., and Yoshizawa H. Effect of mechanical compression on the lumbar nerve root: localization and changes of intraradicular inflammatory cytokines, nitric oxide, and cyclooxygenase. Spine 30 (2005) 1699-1705
11. Linton M.F., and Fazio S. Cyclooxygenase-2 and inflammation in atherosclerosis. Curr. Opin. Pharmacol. 4 (2004) 116-123
12. Ma W., and Eisenach J.C. Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain. Eur. J. Neurosci. 15 (2002) 1037-1047
13. Mayer S., Izydorczyk I., Reeh P.W., and Grubb B.D. Bradykinin-induced nociceptor sensitisation to heat depends on cox-1 and cox-2 in isolated rat skin. Pain 130 (2007) 14-24
14. Nemade R.V., Lewis A.I., Zuccarello M., and Keller J.T. Immunohistochemical localization of endothelial nitric oxide synthase in vessels of the dura mater of the Sprague-Dawley rat. Neurosci. Lett. 197 (1995) 78-80
15. Pfaffenrath V., and Scherzer S. Analgesics and NSAIDs in the treatment of the acute migraine attack. Cephalalgia 15 Suppl 15 (1995) 14-20
16. Prior M.J., Cooper K.M., May L.G., and Bowen D.L. Efficacy and safety of acetaminophen and naproxen in the treatment of tension-type headache. A randomized, double-blind, placebo-controlled trial. Cephalalgia 22 (2002) 740-748
17. Reddy S.T., Wadleigh D.J., and Herschman H.R. Transcriptional regulation of the cyclooxygenase-2 gene in activated mast cells. J. Biol. Chem. 275 (2000) 3107-3113
18. Schiltz J.C., and Sawchenko P.E. Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J. Neurosci. 22 (2002) 5606-5618
19. Shin T., Lee Y., and Sim K.B. Involvement of cyclooxygenase-1 and -2 in the sciatic nerve of rats with experimental autoimmune neuritis. Immunol. Invest. 32 (2003) 123-130
20. Smith T.R., Sunshine A., Stark S.R., Littlefield D.E., Spruill S.E., and Alexander W.J. Sumatriptan and naproxen sodium for the acute treatment of migraine. Headache 45 (2005) 983-991
21. Strassman A.M., and Levy D. Response properties of dural nociceptors in relation to headache. J. Neurophysiol. 95 (2006) 1298-1306
22. Strassman A.M., Raymond S.A., and Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature 384 (1996) 560-564
23. Turini M.E., and DuBois R.N. Cyclooxygenase-2: a therapeutic target. Annu. Rev. Med. 53 (2002) 35-57
24. Wienecke T., Olesen J., Oturai P.S., and Ashina M. Prostacyclin (epoprostenol) induces headache in healthy subjects. Pain 139 (2008) 106-116
25. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., and Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11 (1993) 371-386
26. Zeilhofer H.U., and Brune K. Analgesic strategies beyond the inhibition of cyclooxygenases. Trends Pharmacol. Sci. 27 (2006) 467-474
27. Zhang X., Strassman A.M., Burstein R., and Levy D. Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. J. Pharmacol. Exp. Ther. 322 (2007) 806-812